PharmaReports: Neurodegenerative & Neuroelectrophysiological Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel focusses on the chronic neurodegenerative disorders. Reports investigating memory/cognitive decline are also listed here unless they are clearly unrelated to neurodegeneration. In addition, reports relating to acute neurodegeneration such as stroke and cerebral hemorrhage can be included here.
Showing results 101 - 150 of 162
- Alzheimers Disease Biomarkers, 2009
- Epilepsy - Future market upgrade following new drug launches
- Pharmaceutical Company Outlook to 2013
- Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape
- UpdatesPlus Nicotinic Receptors - Current Research and Development - February 2009
- Point of Care Testing - Special Conference
- UpdatesPlus Nicotinic Receptors - Current Research and Development - March 2009
- The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- The Global Multiple Sclerosis Market 2009-2024
- Stem Cells - World Analysis 2009-2024
- Companion Biomarkers in Drug Development
- Alzheimer's Disease: Markets, Pipeline and Opportunities 2009
- Therapeutic Monoclonal Antibodies Markets
- Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success
- Vaccine antigen delivery technologies - Molecular systems to open new markets
- New Approaches to Pharma Research and Development: Evolving strategies to rejuvenate Research and Development efficiency
- Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
- UpdatesPlus Nicotinic Receptors - Current Research and Development - June 2009
- Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
- Accelerating Lead Generation: Emerging technologies and strategies
- Innovations in Protein Kinase Therapies: Company pipelines, therapeutic applications and market forecasts
- UpdatesPlus Nicotinic Receptors - Current Research and Development - July 2009
- UpdatesPlus Nicotinic Receptors - Current Research and Development - September 2009
- Stroke: Competitive Treatments and Market Entry Considerations, 2010
- Monoclonal Antibody Therapeutics 2009-2024
- World Generics Market 2009-2024
- World Neurodegenerative Diseases Market 2009-2024
- Amyotrophic Lateral Sclerosis - Therapy Area Pipeline Report
- World Neurodegenerative Diseases Market 2009-2024
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Global Pharmaceutical Biotech Market 2010-2025
- Pipeline Insight: Multiple Sclerosis - Risk-benefit ratio under the spotlight for potent pipeline drugs
- Therapeutic Vaccines - A far-off promise of greatness
- What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and Other Vaccine Targets in the 2010-2020 Pipeline
- Alzheimer's Disease: Current Treatment Practices and Opportunities, 2010
- Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
- Pipeline Insight: Alzheimer's Disease - The ultimate high-risk, high-reward therapy market
- Pipeline Insight: Mild Cognitive Impairment - Unlocking the potential of prodromal Alzheimer's disease and beyond
- Stakeholder Opinions: Spinal Cord Injury - Attractive niche market with multi-billion dollar potential
- Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016
- The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis
- Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
- Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
- The Future of the Neurology Devices Market to 2016 – Market Forecasts, Competitive Landscape and Pipeline Analysis
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development